Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity.

Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity.

Item
http://www.wikidata.org/entity/Q34394744
Shigellosis: Epidemiology in IndiaVaccines against human diarrheal pathogens: current status and perspectivesAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.Broadly protective Shigella vaccine based on type III secretion apparatus proteins.Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Expression of Shigella flexneri ipaB Gene in Tobacco.Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults.Progress and pitfalls in Shigella vaccine research.An update on vaccines against Shigella.Recent progress towards development of a Shigella vaccine.The role of oxyR and soxRS in oxidative stress survival in Shigella flexneri.
P2860

Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity.

Item
http://www.wikidata.org/entity/Q34394744
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Characterization of WRSs2 and ...... al for reduced reactogenicity.
@ast
Characterization of WRSs2 and ...... al for reduced reactogenicity.
@en
Characterization of WRSs2 and ...... al for reduced reactogenicity.
@nl
type
label
Characterization of WRSs2 and ...... al for reduced reactogenicity.
@ast
Characterization of WRSs2 and ...... al for reduced reactogenicity.
@en
Characterization of WRSs2 and ...... al for reduced reactogenicity.
@nl
prefLabel
Characterization of WRSs2 and ...... al for reduced reactogenicity.
@ast
Characterization of WRSs2 and ...... al for reduced reactogenicity.
@en
Characterization of WRSs2 and ...... al for reduced reactogenicity.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Characterization of WRSs2 and ...... al for reduced reactogenicity.
@en
P2093
P2860
P304
P31
P356
10.1016/J.VACCINE.2009.11.001
P407
P433
P478
P577
P5875
P698
P932